Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Classificação em ações #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Preço da ação
$4.06
Última sincronização: 2024-02-23
Valor de mercado
$145.61M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Theseus Pharmaceuticals, Inc. (THRX)

Categoria

Histórico de preços das ações de Theseus Pharmaceuticals, Inc. (THRX)
Preço de fecho mais alto: $4.07 em 2024-02-01

Preço de fecho mais baixo: $16.20 em 2021-10-01
Histórico de preços das ações da Theseus Pharmaceuticals, Inc. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 5.46%
2023 -30.80%
2022 -54.19%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH